Hiroki Hikasa
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
SAMD4 represses VGLL4 mRNA to activate TEAD and promote cancer progression.
Journal: Oncogene
Published: October 09, 2025
MOB1 deletion in murine mature adipocytes ameliorates obesity and diabetes.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 21, 2025
N-(3,4-dimethoxyphenethyl)-6-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-amine inhibits bladder cancer progression by suppressing YAP1/TAZ.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: July 21, 2022
Endogenous YAP1 activation drives immediate onset of cervical carcinoma in situ in mice.
Journal: Cancer science
Published: May 04, 2020
YAP1 is a potent driver of the onset and progression of oral squamous cell carcinoma.
Journal: Science advances
Published: June 12, 2019
Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: December 25, 2015
Wnt signaling in vertebrate axis specification.
Journal: Cold Spring Harbor perspectives in biology
Published: August 24, 2012
Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.
Journal: The Journal of clinical investigation
Published: March 08, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026